David Hull
Van Bael & Bellis (Brussels)
Partner
David Hull is a highly-experienced competition lawyer, having started practicing competition law in Brussels in 1984. He specializes in representing clients in complex investigations before the European Commission and in litigation before the European Courts. Notable cases include Lundbeck (first EU case on “reverse-payment” patent settlements) ; Cathode Ray Tubes (appeal of cartel decision) ; Ryanair (appeal of Commission’s decision blocking takeover of Aer Lingus) ; Akzo (legal privilege) ; Bitumen (appeal of fine imposed in cartel case) ; and Microsoft (appeal of fine imposed for alleged non-compliance with Commission decision). He teaches competition law at the University of Liège and the Brussels School of Competition.
Auteurs associés
Jean-François Bellis
Van Bael & Bellis (Brussels)
Van Bael & Bellis
Van Bael & Bellis
Katharina Bongs
Van Bael & Bellis (Brussels)
Michel Bonne
Van Bael & Bellis (Brussels)
Richard Burton
Van Bael & Bellis (Brussels)
1679 | Évènements
Articles
5118 Bulletin
103
On 15 June 2022, the General Court of the European Union (“GC”) upheld all of Qualcomm’s arguments and therefore annulled the decision of the European Commission (“Commission”) fining Qualcomm € 1 billion for abuse of dominant position on the Long-Term Evolution (“LTE”) chipsets market. In (...)
84
On 31 March 2022, the CMA published one of its longest decisions (1077 pages), in which it imposed fines of £155 million on Accord-UK (previously Auden McKenzie/Actavis) for excessive price increases on hydrocortisone tablets after they were de-branded and fell outside the UK NHS price (...)
64
On 24 March 2022, an Italian administrative court (“TAR Lazio” or “court”) annulled the Italian Competition Authority (“ICA”) decision imposing a fine of €10.8 million on several companies belonging to the music ticketing and marketing group CTS Eventim-TicketOne (“TicketOne”) for abuse of its (...)
213
On 31 March 2022, the CMA published one of its longest decisions (1077 pages), in which it imposed fines of £155 million on Accord-UK (previously Auden McKenzie/Actavis) for excessive price increases on hydrocortisone tablets after they were de-branded and fell outside the UK NHS price (...)
114
On 20 October 2020, the Swiss Competition Commission (“COMCO”) fined UPC (a group member of Liberty Global) CHF 30 million for abuse of dominance for refusing to supply live broadcasts of the Swiss Ice Hockey Championship to Swisscom. UPC was found to be dominant on the basis of its exclusive (...)
155
On 14 October 2020, the French Supreme Court (“Cour de Cassation”) confirmed the Court of Appeals’ finding that horserace-betting company Pari Mutuel Urbaine (“PMU”) abused its dominant position in the market for physical horserace betting by pooling bets with those in the online market. (...)
105
On 7 October 2020, the European Commission accepted Broadcom’s commitments to suspend its existing agreements, and to refrain from entering into any new agreements, containing exclusivity or quasi-exclusivity arrangements and/or leveraging provisions concerning Systems-on-a-Chip (“SoCs”) for TV (...)
2651
In the last few years, the European Commission and national competition authorities have demonstrated an increased interest in investigating and punishing gun jumping. This development is part of a broader effort by the Commission to tighten its review of compliance with procedural aspects of the EU’s merger control regime.
500
On 17 July 2009, the European Commission approved the acquisition by Pfizer Inc. USA (« Pfizer ») of Wyeth USA. In its decision, the Commission identified substantial horizontal overlaps in the parties’ human health pharmaceutical operations, as well as in the parties’ animal health operations, (...)
1129
On 22 June 2009, the European Commission approved the acquisition by Deutsche Lufthansa AG (« Lufthansa ») of SN Airholding SA/NV, the holding company of SN Brussels Airlines (« SN Brussels »), subject to commitments. This decision indicates that the Commission is moving towards a more nuanced (...)
16744 Revue
209
Comm. eur., déc. art.6, § 1 (b) et art. 6, § 2, R. 139/2004 du 6 novembre 2012, ARM c/ Giesecke & Devrient/Gemalto c/ JV Trustonic : Du faux départ à la ligne d’arrivée La mi-décembre 2012 a vu le démarrage de Trustonic, l’entreprise commune créée par ARM, Gemalto et Giesecke & Devrient (G&D) (...)
516
Comm. eur., déc. art. 6, §1 (b), R. 139/2004 du 20 octobre 2011, Aelia/Aéroports de Paris/JV, aff. COMP/M.6263 Le 20 octobre 2011, la Commission européenne a donné son feu vert à la création d’une entreprise commune à Aelia (contrôlée par le groupe Lagardère) et Aéroports de Paris (“ADP”) pour (...)
291
Comm. eur., déc. art. 6, §1 (b), R. 139/2004 du 7 novembre 2011, Arla Foods/Allgäuland, aff. COMP/M.6348 Arla, coopérative laitière danoise, active sur les marchés de la production et de la vente de plusieurs produits laitiers, a pour ambition de devenir l’un des leaders sur le marché allemand de la (...)
640
Eur. comm., 21 December 2010, News Corp/BSkyB, case COMP/M.5932 By its decision of 21 December 2010, the European Commission cleared News Corp’s proposed acquisition of the remaining 60.86 % of the shares in BSkyB that it did not already own. The transaction will bring together Rupert Murdoch’s (...)
209
Comm. eur., déc. art. 8, §2, R.139/2004, du 17 novembre 2010, Unilever/Sara Lee Body Care, aff. COMP/M.5658 La Commission européenne a publié le 27 janvier 2012 sa décision concernant l’acquisition par Unilever des activités “entretien et soins de la personne” de Sara Lee. Elle avait donné son aval (...)
1616
Eur. comm., dec. art. 6(2) Reg. 139/2004, 3 August 2010, Teva/Ratiopharm, case COMP/M.5865 On 3 August 2010, the European Commission cleared, subject to conditions and obligations, the acquisition by Teva Pharmaceutical Industries Limited (« Teva ») of Merckle GmbH, CT Arzneimittel GmbH and (...)
1213
– Eur. comm., 17 June 2010, Procter & Gamble/Sara Lee Air Care, case COMP/M.5828 On 17 June 2010, the European Commission approved Procter & Gamble’s acquisition of Sara Lee’s air care business. Procter & Gamble is a U.S. corporation that develops, manufactures, markets and sells a (...)
1465
– Comm. eur., 21 janvier 2010, Oracle/Sun Microsystems, aff. COMP/M.5529 Par sa décision du 21 janvier 2010, la Commission européenne a autorisé l’acquisition du vendeur américain de logiciels et matériel informatique Sun Microsystems par la société américaine de base de données Oracle au terme d’une (...)
1551
– Comm. eur., 22 octobre 2009, Merck/Schering Plough, aff. COMP/M.5502 Le 22 octobre 2009, la Commission européenne a autorisé l’acquisition de la société pharmaceutique américaine Schering-Plough par Merck, une autre société pharmaceutique américaine. La présente décision concerne principalement le (...)
4878
La Commission européenne vient d’adopter, le 8 juillet 2009, son rapport d’enquête final sur le secteur pharmaceutique. Ce rapport souligne que les retards observés dans la mise sur le marché des médicaments génériques et le recul apparent de l’innovation dans le secteur pharmaceutique découlent de (...)
2160
– Eur. Commission, 17 July 2009, Pfizer/Wyeth, Case COMP/M.5476 On 17 July 2009, the European Commission approved the acquisition by Pfizer Inc. USA (“Pfizer”) of Wyeth USA. In its decision, the Commission identified substantial horizontal overlaps in the parties’ human health pharmaceutical (...)
1996
– Eur. Commission, 22 June 2009, Lufthansa/SN Airholdings, Case COMP/M.5335 On 22 June 2009, the European Commission approved the acquisition by Deutsche Lufthansa AG (“Lufthansa”) of SN Airholding SA/NV, the holding company of SN Brussels Airlines (“SN Brussels”), subject to commitments. This (...)
Livres
Prix
290,00 €
2020 Competition Case Law Digest - A Synthesis of EU, US and National Leading Cases
Date
31 janvier 2020
Prix
290,00 €
